Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Physician Leaders and the Business of Medicine

From the College  |  November 1, 2008

In a perfect world, in their work, all people would do what they do best—and only what they do best. Dancers would dance, singers would sing, and physicians and healthcare professionals would spend their time treating patients, teaching, and advancing the science of their profession.

Letters to the Editor

Staff  |  November 1, 2008

I read with interest Dr. Fox’s perspective in the June issue of The Rheumatologist [TR] regarding ghost writing in medical research. Dr. Fox is all for integrity in research (who isn’t?); nevertheless, he takes to task some of the people (Ross et al and the editors of the Journal of the American Medical Association [JAMA]) who write about the corrupting influence of industry on physicians, including those in academics [JAMA 2008;299(15):1800-1812]. Part of his motivation may be to defend members of ACR who have been involved in the activity of ghostwriting and guest editing. This approach may play well to readers of The Rheumatologist, but it would seem that Dr. Fox should address his concerns to the editors of JAMA. That way, the authors of the article could offer a rebuttal to Dr. Fox’s concerns and assertions, and we all could get closer to the truth about this important issue.

Curing Epidemics at the Strep Lab

Alton J. Morris, MD  |  November 1, 2008

A valuable early research education

Enact Change in RA

David S. Pisetsky, MD, PhD  |  November 1, 2008

Future advances could be challenged by structural barriers within the specialty

Looking Ahead to 2009

Sherine Gabriel, MD  |  November 1, 2008

Moving forward and reflecting back

Experts Debate Merits of Peripheral MRI in Diagnosing RA

Greg Lavine  |  November 1, 2008

New technology comes with a host of pros and cons

The Bone and Joint Decade at the 4/5ths Mark

Gretchen Henkel  |  November 1, 2008

Missions accomplished?

Cellular Therapy of Autoimmune Disease

Alan Tyndall, MD  |  November 1, 2008

Is a novel treatment breakthrough on the horizon?

A Regulatory Leader in Rheumatology

Gretchen Henkel  |  October 1, 2008

Jeffrey Siegel, MD: A rare combination of clinical scientist and regulatory collaborator

Medical Decision Making and Coding

Melesia Tillman, CPC, CCP  |  October 1, 2008

In my years of coding for rheumatology, I am often asked this type of question: “I have a patient who recently came in for a visit. She had two or three diagnoses, was placed on three or four different medications, and we ran one or two labs on her. Does this qualify for a level-four visit?”

  • « Previous Page
  • 1
  • …
  • 771
  • 772
  • 773
  • 774
  • 775
  • …
  • 814
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences